Biogen Int’l GmbH v. Amneal Pharmaceuticals LLC
Case Name: Biogen Int’l GmbH v. Amneal Pharmaceuticals LLC, Civ. No. 17-823 (MN), 2020 WL 5549084 (D. Del. Sept. 16, 2020) (Noreika, J.) Drug Product and Patent(s)-in-Suit: Tecfidera® (dimethyl...
View ArticleNew ANDA Cases
This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are filed pursuant to the Hatch-Waxman Act. It also includes the same...
View ArticleGeneric Launches
This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug Applications and 505(b)(2) Applications....
View ArticleANDA Litigation Settlements
This chart summarizes the case name, drug, patents-in-suit, and publicly available terms for reported settlements in federal district court cases that are filed pursuant to the Hatch-Waxman Act....
View ArticleANDA Approvals
This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA. table.tableizer-table {...
View ArticleValuation: The “Eye of the Beholder” Causes Disputes
The need to value closely held corporations and associated real estate frequently arises in the context of estate administration. The value of such assets, however, is often fogged by the differing...
View ArticleThe IRS Says “Nice Try.” Case Illustrations of Unsuccessful Valuation Efforts
In the context of valuation, legal professionals have at times utilized creative efforts to shield clients from tax exposure. It is perhaps unsurprising therefore that whether the focus involves art, a...
View ArticleFrom the Trenches: A Spotlight Interview with Larry Farese
The Spotlight had a chance to sit down with longtime Robins Kaplan trial attorney and mediator Larry Farese for a good old-fashioned story telling session.
View Article